SeaCrest Wealth Management LLC reduced its stake in shares of DocuSign, Inc. (NASDAQ:DOCU – Free Report) by 5.2% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,739 shares of the company’s stock after selling 588 shares during the quarter. SeaCrest Wealth Management LLC’s holdings in DocuSign were worth $575,000 at the end of the most recent quarter.
Other institutional investors have also recently bought and sold shares of the company. Dakota Wealth Management increased its stake in DocuSign by 0.8% in the second quarter. Dakota Wealth Management now owns 23,022 shares of the company’s stock valued at $1,232,000 after purchasing an additional 181 shares in the last quarter. Assenagon Asset Management S.A. raised its stake in DocuSign by 24.8% during the 2nd quarter. Assenagon Asset Management S.A. now owns 618,118 shares of the company’s stock worth $33,069,000 after buying an additional 122,992 shares during the period. Baader Bank Aktiengesellschaft lifted its holdings in DocuSign by 13.0% during the second quarter. Baader Bank Aktiengesellschaft now owns 17,517 shares of the company’s stock worth $937,000 after acquiring an additional 2,017 shares in the last quarter. PGGM Investments grew its stake in DocuSign by 36.7% in the second quarter. PGGM Investments now owns 49,812 shares of the company’s stock valued at $2,665,000 after acquiring an additional 13,379 shares during the period. Finally, DMC Group LLC increased its holdings in shares of DocuSign by 9.5% in the second quarter. DMC Group LLC now owns 4,360 shares of the company’s stock worth $233,000 after acquiring an additional 378 shares in the last quarter. Institutional investors own 77.64% of the company’s stock.
Insider Buying and Selling at DocuSign
In related news, Director Teresa Briggs sold 499 shares of the stock in a transaction on Friday, May 31st. The stock was sold at an average price of $54.92, for a total value of $27,405.08. Following the completion of the sale, the director now directly owns 6,668 shares in the company, valued at $366,206.56. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, Director Teresa Briggs sold 499 shares of DocuSign stock in a transaction that occurred on Friday, May 31st. The stock was sold at an average price of $54.92, for a total value of $27,405.08. Following the transaction, the director now directly owns 6,668 shares of the company’s stock, valued at $366,206.56. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider James P. Shaughnessy sold 1,800 shares of the company’s stock in a transaction that occurred on Tuesday, June 11th. The shares were sold at an average price of $50.98, for a total value of $91,764.00. Following the completion of the sale, the insider now owns 35,703 shares in the company, valued at $1,820,138.94. The disclosure for this sale can be found here. In the last ninety days, insiders sold 475,192 shares of company stock worth $25,095,034. 1.66% of the stock is currently owned by company insiders.
DocuSign Price Performance
DocuSign (NASDAQ:DOCU – Get Free Report) last announced its quarterly earnings results on Thursday, June 6th. The company reported $0.29 EPS for the quarter, beating analysts’ consensus estimates of $0.20 by $0.09. The firm had revenue of $709.64 million for the quarter, compared to analyst estimates of $706.07 million. DocuSign had a return on equity of 15.44% and a net margin of 3.81%. As a group, equities research analysts anticipate that DocuSign, Inc. will post 0.88 earnings per share for the current fiscal year.
Analyst Ratings Changes
A number of research firms recently issued reports on DOCU. Robert W. Baird lowered their target price on DocuSign from $65.00 to $55.00 and set a “neutral” rating for the company in a research note on Friday, June 7th. Piper Sandler lowered their target price on DocuSign from $65.00 to $60.00 and set a “neutral” rating for the company in a report on Friday, June 7th. Citigroup reduced their price objective on DocuSign from $93.00 to $86.00 and set a “buy” rating for the company in a research report on Wednesday, June 5th. Needham & Company LLC restated a “hold” rating on shares of DocuSign in a report on Friday, August 16th. Finally, Royal Bank of Canada lowered their price target on DocuSign from $59.00 to $52.00 and set a “sector perform” rating on the stock in a research report on Friday, June 7th. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $59.36.
View Our Latest Analysis on DocuSign
DocuSign Company Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Stories
- Five stocks we like better than DocuSign
- What Is WallStreetBets and What Stocks Are They Targeting?
- Target Hits the Mark: Q2 Earnings Exceed Expectations
- How to Find Undervalued Stocks
- Is Tesla’s Rebound Just Starting? Why You Should Consider Buying
- 5 discounted opportunities for dividend growth investors
- Stanley Druckenmiller’s Latest Bet: MELI—Should You Follow Suit?
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocuSign, Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.